Infants With Spinal Muscular Atrophy Type I
Stopped early
Conditions studied: Spinal Muscular Atrophy
In brief
Background: \- Spinal muscular atrophy type 1 (SMA 1) causes severe muscle weakness and problems with eating and breathing. The symptoms begin in infancy, and children affected with SMA 1 often die in early childhood. Researchers want to collect information on how SMA symptoms progress in first two years. Objectives: \- To study how the symptoms of SMA 1 progress in infants and children. Eligibility: \- Infants and children with SMA 1 born on or after January 1, 2007. Design: * Researchers will review the child s medical records and talk with parents by telephone. * For children who are under 2 years of age, the researchers will review the child s medical records and speak with you on telephone every 2-4 months. Phone calls with parents will take about 10 minutes and will involve questions about symptoms of SMA 1. Children will be followed until age 2.- Researchers are also interested in looking at medical records of children who are no longer alive or who are more than 2 years of age. Parents or children do not have to come to the NIH. They will provide consent to view these records, and information over the telephone. \- No treatment or care will be provided as part of this study.
Key facts
- Study ID
- NCT01547871
- Run by
- National Institute of Neurological Disorders and Stroke (NINDS)
- People needed
- 4
- Starts
- 2012-02-07
- Expected to finish
- 2016-04-14
- Last updated by the study team
- 2019-12-12
Who can join
Age: 1 and older, up to 6. Sex: any. Healthy volunteers: not accepted.
Where it is running
- National Institute of Neurological Disorders and Stroke (NINDS), 9000 Rockville — Bethesda, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.